Literature DB >> 33196543

Endophthalmitis after cataract surgery: an update on recent advances.

Travis J Peck1, Samir N Patel, Allen C Ho.   

Abstract

PURPOSE OF REVIEW: Prevention and management of postcataract endophthalmitis remain quite relevant for anterior segment and vitreoretinal surgeons. Although the Endophthalmitis Vitrectomy Study, published in 1996, remains the only level 1 evidence for the management of postcataract endophthalmitis, recent advances have resulted in an evolution of practice patterns. The aim of this review is to summarize the literature regarding postcataract endophthalmitis with a focus on the last 18 months. RECENT
FINDINGS: The IRIS registry indicates the rates of endophthalmitis are decreasing in the United States, and the outcomes appear to be improving. Intracameral moxifloxacin has become more widely accepted and intracameral vancomycin has been shown to be associated with retinal vasculitis. The role of systemic antibiotics and vitrectomy is unclear and practice patterns vary widely.
SUMMARY: Although practice patterns vary, prevention and treatment of endophthalmitis after cataract surgery continues to improve. More uniform guidelines regarding surgical and medical therapy are necessary but the standard of prompt referral to a vitreoretinal specialist for immediate intravitreal antibiotics remains the most important intervention in the management of postcataract endophthalmitis.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33196543     DOI: 10.1097/ICU.0000000000000727

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  2 in total

Review 1.  The Role of Metalloproteinases and Their Tissue Inhibitors on Ocular Diseases: Focusing on Potential Mechanisms.

Authors:  Miłosz Caban; Katarzyna Owczarek; Urszula Lewandowska
Journal:  Int J Mol Sci       Date:  2022-04-12       Impact factor: 6.208

2.  Emerging Antibiotic Resistance Patterns Affect Visual Outcome Treating Acute Endophthalmitis.

Authors:  Xia-Ni Wu; Yi-Hsing Chen; Lazha Sharief; Ahmed Al-Janabi; Nura Al Qassimi; Sue Lightman; Oren Tomkins-Netzer
Journal:  Antibiotics (Basel)       Date:  2022-06-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.